Global Erectile Dysfunction Market 2016-2020

  • ID: 3920550
  • Report
  • Region: Global
  • 70 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Apricus Biosciences
  • Boston Scientific
  • Dong-A Socio
  • Endo Pharmaceuticals
  • Meda Pharmaceuticals
  • Promedon
  • MORE
About Erectile Dysfunction

The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels. The condition can be treated with a broad range of drugs and implants available in the market.

The analysts forecast the global erectile dysfunction treatment market to witness a slow grow in market size of USD 4.08 billion during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global erectile dysfunction treatment market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of different types of penile implants, ED creams, and drugs, including branded and generic drugs.

The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

The report, Global Erectile Dysfunction Treatment Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Bayer
- Boston Scientific
- Coloplast
- Eli Lilly
- Pfizer

Other prominent vendors
- Apricus Biosciences
- Cristalia Produtos Quimicos Farmaceuticos
- Dong-A Socio
- Endo Pharmaceuticals
- Futura Medical
- Meda Pharmaceuticals
- Promedon
- SK Chemical
- Teva Pharmaceuticals
- Vivus
- Zephyr Surgical Implants (ZSI)

Market drivers
- Demand from older adult male population

Market challenges
- Threat of counterfeit products

Market trends
- Migration of manufacturing and sales facilities to APAC

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Apricus Biosciences
  • Boston Scientific
  • Dong-A Socio
  • Endo Pharmaceuticals
  • Meda Pharmaceuticals
  • Promedon
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Definition
  • Vendor segmentation
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by product
  • Global ED treatment market by product
  • Global ED drugs market
  • Global ED devices market
PART 07: Market segmentation by type of ED drugs
  • Global ED treatment market by type of ED drugs
PART 08: Market segmentation by type of ED device
  • Global ED treatment market by type of ED device
PART 09: Geographical segmentation
  • Global ED treatment market by geography
  • ED treatment market in Americas
  • ED treatment market in EMEA
  • ED treatment market in APAC
PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape
  • Competitive scenario
PART 16: Key vendor analysis
  • Bayer
  • Boston Scientific
  • Coloplast
  • Eli Lilly
  • Pfizer
  • Other prominent vendors
PART 17: Appendix
  • List of abbreviations
PART 18: About the Author

List of Exhibits

Exhibit 01: Global erectile dysfunction treatment market by product
Exhibit 02: Key countries
Exhibit 03: Product offerings
Exhibit 04: Major causes of ED
Exhibit 05: Global ED treatment market 2015-2020 ($ billions)
Exhibit 06: Key drug patent expirations in major countries
Exhibit 07: Five forces analysis
Exhibit 08: Global ED treatment market by product 2015 and 2020
Exhibit 09: Global ED treatment market by product 2015-2020
Exhibit 10: Global ED drugs market 2015-2020 ($ billions)
Exhibit 11: Global ED devices market 2015-2020 ($ millions)
Exhibit 12: ED device market by geography 2015 and 2020
Exhibit 13: Global ED treatment market by type of ED drugs 2015
Exhibit 14: Global ED treatment market by type of ED device 2015 and 2020
Exhibit 15: Global ED treatment market by geography 2015 and 2020
Exhibit 16: Global ED treatment market by geography 2015-2020 ($ millions)
Exhibit 17: ED treatment market in Americas 2015-2020 ($ billions)
Exhibit 18: ED treatment market in Americas by drugs and devices
Exhibit 19: ED treatment market in EMEA 2015-2020 ($ billions)
Exhibit 20: Occurrence of ED by age 2015
Exhibit 21: ED treatment market in EMEA by drugs and devices 2015 and 2020
Exhibit 22: ED treatment market in APAC 2015-2020 ($ millions)
Exhibit 23: ED treatment market in APAC by drugs and devices 2015 and 2020
Exhibit 24: ED treatment Market by product across regions 2015 and 2020 ($ million)
Exhibit 25: Estimated cancer cases and deaths in US 2016 (thousands)
Exhibit 26: Chances of men developing ED by age in the US
Exhibit 27: Number of individuals with diabetes around the world 2015 and 2040 (millions)
Exhibit 28: Impact of drivers
Exhibit 29: Impact of drivers and challenges
Exhibit 30: Bayer: Key takeaways
Exhibit 31: Boston Scientific: Key takeaways
Exhibit 32: Coloplast: Key takeaways
Exhibit 33: Eli Lilly: Key takeaways
Exhibit 34: Pfizer: Key takeaways
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Apricus Biosciences
  • Boston Scientific
  • Dong-A Socio
  • Endo Pharmaceuticals
  • Meda Pharmaceuticals
  • Promedon
  • MORE
New Report Released: - Global Erectile Dysfunction Treatment Market 2016-2020

The author of the report recognizes the following companies as the key players in the global erectile dysfunction treatment market: Bayer, Boston Scientific, Coloplast, Eli Lilly, and Pfizer.

Other Prominent Vendors in the market are: Apricus Biosciences, Cristalia Produtos Quimicos Farmaceuticos, Dong-A Socio, Endo Pharmaceuticals, Futura Medical, Meda Pharmaceuticals, Promedon, SK Chemical, Teva Pharmaceuticals, Vivus, and Zephyr Surgical Implants (ZSI).

Commenting on the report, an analyst from the research team said: “One of the key drivers for market growth will be migration of manufacturing and sales facilities to APAC. In the recent years many manufacturers of ED products have either established or expanded their current manufacturing and sales network in APAC. This is primarily to capitalize on the high number of ED cases, economy of production offered, and to find easy access to domestic markets at a cheaper logistical cost. The region provides an attractive proposition of low cost of land and material, easily availability of labour, and access to a larger population that will contribute to the growth of the market in the future.”

According to the report, demand from older adult male population will be a key driver for market growth. An increase in sophisticated treatment options and improved standards of healthcare facilities have resulted in an increase in the life expectancy rates leading to a growing older adult population worldwide. With age, the physical, and hormonal changes in the body can cause a decrease in libido, which is a side effect of ED that can occur at any age. ED is more common among older men; seen mostly in men over 40 years of age. The increase in chances of older men getting affected by ED is associated with an unhealthy lifestyle and an increase in stress related activities over the years leading to a decrease in level of libido.

Further, the report states that the main challenge for the market is the patent expiration of major drugs, which will lead to the introduction of a broad range of generic drugs of similar chemical composition for the treatment of ED. These drugs will be available at a much cheaper cost, which can be attributed to limited legal procedures as well as less production expenses related to these generic drugs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Bayer
- Boston Scientific
- Coloplast
- Eli Lilly
- Pfizer
- Apricus Biosciences
- Cristalia Produtos Quimicos Farmaceuticos
- Dong-A Socio
- Endo Pharmaceuticals
- Futura Medical
- Meda Pharmaceuticals
- Promedon
- SK Chemical
- Teva Pharmaceuticals
- Vivus
- Zephyr Surgical Implants (ZSI)
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll